Thermal characterization and compatibility studies of norfloxacin for development of extended release tablets

被引:0
|
作者
P. R. Oliveira
L. S. Bernardi
F. S. Murakami
C. Mendes
M. A. S. Silva
机构
[1] Federal University of Santa Catarina,Department of Pharmaceutical Sciences, Health Science Centre
关键词
Norfloxacin; Thermal characterization; Kinetic studies; Compatibility studies;
D O I
暂无
中图分类号
学科分类号
摘要
Norfloxacin (NFX) is a synthetic antibacterial drug. The development of extended release tablets improves the patients’ comfort and compliance, resulting in lower discontinuation of the therapy; with consequently decrease in bacterial resistance. In the present work, the thermal behavior of NFX was investigated using TG and DSC techniques. Isothermal and non-isothermal methods were employed to determine kinetic data of decomposition process. Compatibility studies between NFX and pharmaceutical excipients, including three hydrophilic polymers were carried out in order to develop a new formulation of NFX to obtain extended release tablets with an approved quality.
引用
下载
收藏
页码:741 / 745
页数:4
相关论文
共 50 条
  • [41] Characterization of Channeling Effects Applied to Extended-Release Matrix Tablets Containing Pirfenidone
    Kang, Ji-hyun
    Yoo, Seung-Dong
    Han, Ki-Hun
    Jeong, So-Jeong
    Lee, Hyo-Jung
    Yoo, Je Hwa
    Shin, Dae Hwan
    Kim, Dong-Wook
    Park, Eun-Seok
    Park, Chun-Woong
    CHEMICAL & PHARMACEUTICAL BULLETIN, 2023, 71 (09) : 678 - 686
  • [42] Physicochemical Characterization of Solid Norfloxacin and Ciprofloxacin Metal Complexes: Spectroscopic and Thermal Studies
    Balboul, Basma A. A.
    Mohamed, Ebtihal S.
    EGYPTIAN JOURNAL OF CHEMISTRY, 2011, 54 (02): : 239 - 256
  • [43] Thermal Analytical Approaches to Characterization and Compatibility Studies of Duloxetine Hydrochloride
    Veiga, Andressa
    Stofella, Nayana C. F.
    Oliveira, Laiane J.
    Montin, Elisa F.
    Bauab, Tabata
    Malucelli, Lucca C.
    Filho, Marco Aurelio S. C.
    Oliveira, Paulo R.
    Murakami, Fabio S.
    PHARMACEUTICAL CHEMISTRY JOURNAL, 2020, 54 (06) : 659 - 666
  • [44] Thermal Analytical Approaches to Characterization and Compatibility Studies of Duloxetine Hydrochloride
    Andressa Veiga
    Nayana C. F. Stofella
    Laiane J. Oliveira
    Elisa F. Montin
    Tábata Bauab
    Lucca C. Malucelli
    Marco Aurélio S. C. Filho
    Paulo R. Oliveira
    Fábio S. Murakami
    Pharmaceutical Chemistry Journal, 2020, 54 : 659 - 666
  • [45] The Effects of Ethanol on the Bioavailability of Oxymorphone Extended-Release Tablets and Oxymorphone Crush-Resistant Extended-Release Tablets
    Fiske, William D.
    Jobes, Janet
    Xiang, Qinfang
    Chang, Sou-Chan
    Benedek, Irma H.
    JOURNAL OF PAIN, 2012, 13 (01): : 90 - 99
  • [46] DIFFERENTIAL SCANNING CALORIMETRY AS A SCREENING TECHNIQUE IN COMPATIBILITY STUDIES OF ACYCLOVIR EXTENDED RELEASE FORMULATIONS
    Barboza, F.
    Vecchia, D. D.
    Tagliari, M. P.
    Silva, M. A. S.
    Stulzer, H. K.
    PHARMACEUTICAL CHEMISTRY JOURNAL, 2009, 43 (06) : 363 - 368
  • [47] Differential scanning calorimetry as a screening technique in compatibility studies of DHEA extended release formulations
    Mora, P. Corvi
    Cirri, M.
    Mura, P.
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2006, 42 (01) : 3 - 10
  • [48] Differential scanning calorimetry as a screening technique in compatibility studies of acyclovir extended release formulations
    F. Barboza
    D. D. Vecchia
    M. P. Tagliari
    M. A. S. Silva
    H. K. Stulzer
    Pharmaceutical Chemistry Journal, 2009, 43 : 363 - 368
  • [49] Clinical development of metformin extended-release tablets for type 2 diabetes: an overview
    Schwartz, Sherwin L.
    Gordi, Toufigh
    Hou, Eddie
    Cramer, Marilou
    Heritier, Michelle
    Cowles, Verne E.
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2008, 4 (09) : 1235 - 1243
  • [50] Unveiling Swelling and Erosion Dynamics: Early Development Screening of Mirabegron Extended Release Tablets
    Ana S. Sousa
    J. Serra
    C. Estevens
    R. Costa
    António J. Ribeiro
    AAPS PharmSciTech, 25 (8)